Loading…
Lobbying Spend
—
Filings
32
Firms Hired
1
Active Period
2009–2016
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2012 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/S. 1096) Endocrine Disruptor Screening Enhancement Act of 2011 (HR 533) Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 (HR 2521/S.1361) Medicare Physician Payment Reform Funding for the National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2020
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011
2012 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/S. 1096) Endocrine Disruptor Screening Enhancement Act of 2011 (HR 533) Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 (HR 2521/S.1361) Medicare Physician Payment Reform Funding for the National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: HR 2521
To provide for the conveyance of a small parcel of Natural Resources Conservation Service property in Riverside, California, and for other purposes.
2012 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/S. 1096) Endocrine Disruptor Screening Enhancement Act of 2011 (HR 533) Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 (HR 2521/S.1361) Medicare Physician Payment Reform Funding for the National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: HR 533
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2012 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/S. 1096) Endocrine Disruptor Screening Enhancement Act of 2011 (HR 533) Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 (HR 2521/S.1361) Medicare Physician Payment Reform Funding for the National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: S. 1096
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2012 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/S. 1096) Endocrine Disrupter Screening Enhancement Act of 2011 (HR 533) Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 (HR 2521/S.1361) Medicare Physician Payment Reform Funding for the National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2020
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011
2012 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/S. 1096) Endocrine Disrupter Screening Enhancement Act of 2011 (HR 533) Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 (HR 2521/S.1361) Medicare Physician Payment Reform Funding for the National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: HR 2521
To provide for the conveyance of a small parcel of Natural Resources Conservation Service property in Riverside, California, and for other purposes.
2012 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/S. 1096) Endocrine Disrupter Screening Enhancement Act of 2011 (HR 533) Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 (HR 2521/S.1361) Medicare Physician Payment Reform Funding for the National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: HR 533
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2012 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/S. 1096) Endocrine Disrupter Screening Enhancement Act of 2011 (HR 533) Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011 (HR 2521/S.1361) Medicare Physician Payment Reform Funding for the National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: S. 1096
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2012 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
H.R. 2020/S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2020
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011
2012 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
H.R. 2020/S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2521
To provide for the conveyance of a small parcel of Natural Resources Conservation Service property in Riverside, California, and for other purposes.
2012 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
H.R. 2020/S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 533
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2012 · second_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
H.R. 2020/S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: S. 1096
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2012 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2020
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011
2012 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2521
To provide for the conveyance of a small parcel of Natural Resources Conservation Service property in Riverside, California, and for other purposes.
2012 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 533
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2012 · first_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: S. 1096
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2011 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2020
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011
2011 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2521
To provide for the conveyance of a small parcel of Natural Resources Conservation Service property in Riverside, California, and for other purposes.
2011 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 533
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2011 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)
Client expense: — · Firm income: $20,000
Matched citations: S. 1096
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2011 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Endocrine Disrupting Chemicals H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2020
Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
2011 · third_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
Fiscal Year 2012 Appropriations for National Institutes of Health Endocrine Disrupting Chemicals H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011
Client expense: — · Firm income: $20,000
Matched citations: S. 1096
American Middle Class Tax (AMT) Relief Act of 2007
2010 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 H.R. 4190, S. 2828 Endocrine Disruptor Screening Enhancement Act of 2010 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S. 3209, Safe Chemicals Act of 2010
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3590
Superfund Polluter Pays Act
2010 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 H.R. 4190, S. 2828 Endocrine Disruptor Screening Enhancement Act of 2010 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S. 3209, Safe Chemicals Act of 2010
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3962
Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
2010 · fourth_quarter · Firm: BRYAN CAVE LEIGHTON PAISNER
H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 H.R. 4190, S. 2828 Endocrine Disruptor Screening Enhancement Act of 2010 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S. 3209, Safe Chemicals Act of 2010
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1894
Source: Senate LDA